Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
Naveed SattarJohn Joseph Valentine McMurrayJan BorénAraz RawshaniElmir OmerovicNiklas BergJanita HolminenKristoffer SkoglundBjorn EliassonUlagamadesan VenkatesanDarren K McGuireDeepak L BhattAidin RawshaniPublished in: Circulation (2023)
Risk and rates for atherosclerotic complications and HF are generally decreasing among individuals with T2D, although HF incidence has notably plateaued in recent years. Modifiable risk factors within target levels were associated with lower risks for outcomes. This was particularly notable for systolic blood pressure and glycated hemoglobin for atherosclerotic outcomes and body mass index for heart failure.